Intellipharmaceutics International Inc. (IPCI)

[fabius]

Guys, numbers from Bloomberg are likely gross revenues. Then rebates, discounts and so on have destroyed profitability.

The real problem to me is that these liars did already know the situation when they made the offerings and they stated to be Nasdaq compliant.
But then they wrote to be non compliant based on final revenue numbers.
They weren't able to calibrate the right proportion of the new offerings.

So honestly there is still somebody who believe that these geniuses could decide to sell generics rights to fund other studies?
Too smart for this group of boy scouts.

And I see that almost nobody realize the risk of asking Nasdaq for an exception without having something bullet proof in your hands.

If we survive it will be by luck and not thanks to strategic planning or contingency management.

Redicolous